Drug Approval | February 27, 2025
Briefs: Emcure and Relonchem
USFDA inspection at Emcure Pharmaceuticals API facility
USFDA inspection at Emcure Pharmaceuticals API facility
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
Among those identified, 2.4 lakh patients have been notified from public health institutions, while 1.1 lakh were identified through private healthcare facilities
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Collaborates with VisionSpring to conduct eye check-up camps for underprivileged children
Zongertinib would be the first orally administered, targeted therapy for previously treated patients with HER2 (ERBB2)-mutant advanced non-small cell lung cancer (NSCLC), if approved
IMCD India’s innovative formulations bring the Skinification trend to life with cutting-edge solutions across beauty and personal care
This strategic partnership will also enable KIMS to exercise call option (not an obligation) to acquire majority stake in UAIMS Hospital in the coming years
This rating reflects Lupin's leadership in environmental transparency and performance
Subscribe To Our Newsletter & Stay Updated
